Key result
Percutaneous extraction using the AngioVac system enabled the debulking of tricuspid valve vegetation in a patient with endocarditis and recurrent septic pulmonary emboli.
Why the study?
Tricuspid valve endocarditis with recurrent septic pulmonary emboli is an indication for surgery, highlighting the need for evidence on percutaneous approaches in complex patients.
Percutaneous extraction using the AngioVac system offers a potential alternative to surgery for tricuspid valve vegetation debulking in complex patients.
Adds to limited data on AngioVac for tricuspid endocarditis; hypothesis-generating and should not yet alter practice.
Tricuspid valve endocarditis with recurrent septic pulmonary emboli is an indication for surgery. We present the case of a 36-year old man with tricuspid valve endocarditis and septic pulmonary emboli with percutaneous extraction of the vegetation. We discuss the nuances of such an approach and the need for more evidence in the management of these complex patients.
No takes yet. Share an insight, caveat, or question.
Bangalore et al. (2021) studied this question. Percutaneous extraction using the AngioVac system enabled the debulking of tricuspid valve vegetation in a patient with endocarditis and recurrent septic pulmonary emboli.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: